Home / Case Studies / Helping a Physician-Scientist Build a Market-Leading Thyroid Cancer Diagnostic
Case study
Helping a Physician-Scientist Build a Market-Leading Thyroid Cancer Diagnostic
From idea to impact: building a global diagnostic company — and preventing thousands of unnecessary surgeries.
- 97%
- negative predictive value
- 48 hrs
- results — vs. 8–10 days
- Global
- scalability via local labs
A surgeon-scientist had a novel molecular diagnostic that could prevent thousands of unnecessary thyroid surgeries every year. The science was compelling; the path to a global diagnostic business — against an entrenched incumbent — was not.
Qanopy helped define the market and build a differentiated strategy against the incumbent: a simpler 10-gene real-time PCR assay delivering results in 48 hours instead of 8–10 days, with 97% negative predictive value — and a kit-based model that runs in local laboratories rather than a single central lab, making it scalable globally.
The engagement identified the right customers and users, shaped the business model, and set the course from breakthrough idea to market-leading diagnostic company — more accurate, faster, and simpler for physicians and patients alike.
Thank you! The full case study is now unlocked below — a copy is on its way to your inbox.